GeneFab
Founded 2023
About GeneFab
GeneFab operates as a contract development, manufacturing, and synthetic biology biofoundry, specializing in cell and gene therapies. Established in 2023, the company focuses on supporting the development and manufacturing processes for innovative therapies. With a team of 35 employees, GeneFab leverages its expertise in synthetic biology to offer comprehensive solutions for the rapid fabrication of large DNA molecules, aiming to advance the field of biotechnology through its contract research, development, and manufacturing services. The company's commitment to innovation is evident in its acquisition of Senti Bio's chemistry, manufacturing, and controls (CMC) capabilities, positioning it as a key player in the biotech industry.
Company Facts
- Founded: 2023
- Legal name: GeneFab LLC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Website: genefab.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/genefab-8421897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.